Korean Biotech’s Shares Quadruple In Seven Months, Becomes Kosdaq’s Biggest Stock
Images: Getty Images; Illustration: Shanshan Kao for Forbes Asia Shares of Alteogen, a little-known biotech company in South Korea, have quadrupled since late February, and now boasts a market capitalization of 18.6 trillion won (about $14 billion). The …